CT/NG Testing Market is Expected to Reach $2.7 Billion | MarketsandMarkets

The CT/NG testing industry is poised for significant growth in the near future due to increasing awareness and prioritization of sexual health. With rising rates of Chlamydia (CT) and Gonorrhea (NG) infections worldwide, healthcare providers and individuals alike are recognizing the importance of early detection and treatment. This surge in demand for CT/NG testing is driving research and technological advancements, leading to the development of more efficient, accurate, and accessible testing methods. Moreover, the integration of telemedicine and at-home testing kits is expected to revolutionize the industry, making it easier for individuals to get tested and receive timely results discreetly. As governments and healthcare organizations continue to emphasize prevention and sexual health education, the CT/NG testing industry will witness a significant expansion in the near future, ultimately leading to better public health outcomes and reduced disease transmission.

CT/NG Testing market in terms of revenue was estimated to be worth $1.7 Billion in 2023 and is poised to reach $2.7 Billion by 2028, growing at a CAGR of 8.6% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Factors such as the rising prevalence of CT/NG infections, growing investments and funds in CT/NG and increasing awareness for CT/NG diagnosis are driving the growth of this market. However, lack of skilled professionals and the high cost of CT/NG testing instruments is likely to hinder the growth of CT/NG testing market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104333528

CT/NG Testing Market Scope:

Report Coverage Details
Market Revenue in 2023 $1.7 Billion
Estimated Value by 2028 $2.7 Billion
Growth Rate Poised to grow at a CAGR of 8.6%
Market Size Available for 2021–2028
Forecast Period 2023–2028
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, testing type, technology, end user, and region
Geographies Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunities Growing  opportunities in emerging countries
Key Market Drivers Increasing investments and funding to drive market growth

CT/NG Testing market major players covered in the report, such as:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Hologic Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • Abbott Laboratories (US)
  • QIAGEN (Netherlands)
  • PerkinElmer Inc. (US)
  • Bio-Rad Laboratories Inc. (US)
  • Siemens Healthineers AG (Germany)
  • Danaher (US)
  • Becton
  • Seegene Inc. (South Korea)
  • Meridian Bioscience Inc. (US)
  • Binx Health Inc. (US)
  • Visby Medical Inc. (US)
  • Geneproof A.S. (Czech Republic)
  • Bioneer Corporation (South Korea)
  • Genetic Signatures (Australia)
  • Microbiologics Inc. (US)
  • Vircell S.L. (Spain)
  • Sansure Biotech Inc. (China)
  • ELITechGroup (France)
  • Molbio Diagnostics Pvt. Ltd. (India)
  • Operon S.A. (Spain)
  • Tianlong Technology Co. Ltd.  (China)
  • and Goffin Molecular Technologies B.V. (Netherlands)
  • and Among Others

Buy CT/NG Testing Industry Report (187 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=104333528

This report categorizes the CT/NG testing market based on product, testing type, technology, end user, and region:

By Product

  • Assays & Kits
  • Instruments/Analyzers

By Testing Type

  • Lab Tests
  • PoC Tests

By Technology

  • Isothermal Nucleic Acid Amplification Technology
  • Polymerase Chain Reaction
  • Immunodiagnostics
  • Other Technologies

By End User

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=104333528

The key stakeholders in the CT/NG Testing market include:

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Frequently Asked Questions (FAQs) of CT/NG Testing Market:

Q1. What is the total market value of CT/NG Testing Market report?

Q2. Which are the top companies holding the market share in CT/NG Testing Market?

Q3. Which are the largest regions for this Market?

Q4. What is the leading technology of CT/NG Testing Market?

Q5. What are the major drivers for this specific Market?

Q6. What are the upcoming key trends in the CT/NG Testing Market report?

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=104333528

Recent Developments:

  • In February 2023, Thermo Fisher Scientific Inc. (US) acquired TIB Molbiol (Germany), to expand its PCR test portfolio with a wide range of assays for infectious diseases.